TargetUbiquitin carboxyl-terminal hydrolase 20(Homo sapiens (Human))
RAPT Therapeutics, Inc.
Curated by ChEMBL
RAPT Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human GST-tagged USP20 expressed in Sf21 insect cells assessed as cleavage of Ubiquitin-Rhodamine110-glycine to Ubiquitin and Rhodamine...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 20(Homo sapiens (Human))
RAPT Therapeutics, Inc.
Curated by ChEMBL
RAPT Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human USP20 using Ub-rhodamine 110 as substrateMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 20(Homo sapiens (Human))
RAPT Therapeutics, Inc.
Curated by ChEMBL
RAPT Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human USP20 using Ub-rhodamine 110 as substrateMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 20(Homo sapiens (Human))
RAPT Therapeutics, Inc.
Curated by ChEMBL
RAPT Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human USP20 using Ub-rhodamine 110 as substrateMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 20(Homo sapiens (Human))
RAPT Therapeutics, Inc.
Curated by ChEMBL
RAPT Therapeutics, Inc.
Curated by ChEMBL
Ligand Info
In DepthDetails